par Ismael, Gustavo ;Rosa, Daniela Dornelles;Azambuja, Evandro ;Braga, S;Piccart-Gebhart, Martine
Référence Hematology/oncology clinics of North America, 21, 2, page (239-256)
Publication Publié, 2007-04
Article révisé par les pairs
Titre:
  • Trastuzumab (herceptin) for early-stage breast cancer.
Auteur:Ismael, Gustavo; Rosa, Daniela Dornelles; Azambuja, Evandro; Braga, S; Piccart-Gebhart, Martine
Informations sur la publication:Hematology/oncology clinics of North America, 21, 2, page (239-256)
Statut de publication:Publié, 2007-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- pathology
Clinical Trials as Topic
Female
Humans
Neoplasm Staging
Receptor, erbB-2 -- biosynthesis
Receptor, erbB-2 -- genetics
Treatment Outcome
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:0889-8588
info:doi/10.1016/j.hoc.2007.03.003
info:pii/S0889-8588(07)00019-6
info:scp/34249048896
info:pmid/17512447